![](/img/cover-not-exists.png)
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
Ruilope, Luis, Hanefeld, Markolf, Lincoff, A, Viberti, Giancarlo, Meyer-Reigner, Sylvie, Mudie, Nadejda, Wieczorek Kirk, Dominika, Malmberg, Klas, Herz, MatthiasVolume:
15
Language:
english
Journal:
BMC Nephrology
DOI:
10.1186/1471-2369-15-180
Date:
December, 2014
File:
PDF, 593 KB
english, 2014